Mark Matijevic
Impact in
-
- Immunotherapy and Immune Responses
-
- RNA Research and Splicing
Papers in
-
- Immunotherapy and Immune Responses 5
- Biosimilars and Bioanalytical Methods 2
-
- Alzheimer's disease research and treatments 3
- Co-authors
- Robert G. Urban (3 shared papers)Mary Lynne Hedley (2 shared papers)Vivian Weinberg (1 shared paper)Teresa M. Darragh (1 shared paper)Maria Da Costa (1 shared paper)Barbara Jane Klencke (1 shared paper)Naomi Jay (1 shared paper)Joel Michael Palefsky (1 shared paper)
- Journals
- Alzheimer s & Dementia (3 papers)Blood (1 paper)Nature Communications (1 paper)Molecular Cancer Therapeutics (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Mark Matijevic
16 papers receiving 947 citations
Peers
Comparison fields: 5 of 60
- Immunology 140
- Molecular Biology 377
- Hematology 60
- Oncology 97
- Epidemiology 116
Countries citing papers authored by Mark Matijevic
This map shows the geographic impact of Mark Matijevic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Matijevic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Matijevic more than expected).
Fields of papers citing papers by Mark Matijevic
This network shows the impact of papers produced by Mark Matijevic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Matijevic. The network helps show where Mark Matijevic may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Matijevic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 367 | |
| 2 | Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101. | 2002 | 200 |
| 3 | 2017 | 116 | |
| 4 | 2017 | 73 | |
| 5 | 2020 | 64 | |
| 6 | 2023 | 46 | |
| 7 | 2011 | 44 | |
| 8 | 2022 | 24 | |
| 9 | 2013 | 20 | |
| 10 | 2012 | 15 | |
| 11 | 2015 | 7 | |
| 12 | 2005 | 4 | |
| 13 | 2024 | 4 | |
| 14 | 2018 | 3 | |
| 15 | 2025 | 2 | |
| 16 | 2015 | 1 |
About Mark Matijevic
Mark Matijevic is a scholar working on Immunology, Physiology, Rheumatology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 16 papers that have together received 990 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Alzheimer's disease research and treatments (3 papers), Cervical Cancer and HPV Research (2 papers), RNA Research and Splicing (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Biosimilars and Bioanalytical Methods (2 papers) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Immunology (140 citations), Molecular Biology (377 citations), Hematology (60 citations), Oncology (97 citations) and Epidemiology (116 citations). Mark Matijevic has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Robert G. Urban, Mary Lynne Hedley, Vivian Weinberg, Teresa M. Darragh, Maria Da Costa, Barbara Jane Klencke, Naomi Jay, Joel Michael Palefsky, Janet L. Lathey and Michael J. Berry. Their work appears in journals such as Alzheimer s & Dementia, Blood, Nature Communications, Molecular Cancer Therapeutics and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.